This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Epigenomics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Noel Doheny
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 13.2yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 4.1yrs |
CEO
Noel Doheny
13.2yrs
Tenure
Dr. Noel Thomas Doheny has been the Chief Executive Officer of Epigenomics Inc. at Epigenomics AG since May 2011. Dr. Doheny manages all US activities and global business development and partnership develo...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Supervisory Board | 8.2yrs | €25.00k | no data | |
| Vice-chairman of Supervisory Board | 4.1yrs | €25.00k | no data | |
| Member of Supervisory Board | less than a year | no data | no data |
4.1yrs
Average Tenure
54yo
Average Age
Experienced Board: ECX's board of directors are considered experienced (4.1 years average tenure).